Xi'an International Medical Investment Company Limited (SZSE:000516) commences share repurchases on December 24, 2018, under the program mandated by the shareholders in the Annual General Meeting held on November 19, 2018. As per the mandate, the company is authorized to repurchase up to CNY 750 million worth of its A shares. The company will spend not less than CNY 350 million for repurchase. The purchase price will not exceed CNY 7.5 per share. The company will use its own funds to repurchase the shares. The plan is valid for 12 months from the date of approval at shareholders' meeting.